Septerna launches with $100M series A financing

By The Science Advisory Board staff writers

January 28, 2022 -- Septerna has launched with $100 million in series A financing. The financing will enable the company to advance its emerging pipeline of novel G protein-coupled receptor (GPCR)-targeted drug programs.

In addition, the company said it will continue to build its industrialized platform to enable drug discovery across the GPCR family and uncover novel mechanisms and new opportunities for previously difficult-to-drug GPCRs to address many diseases.

The company is creating broad new drug discovery opportunities across many disease areas for GPCRs. Septerna's proprietary native complex platform recapitulates GPCRs with their native structure, function, and dynamics outside of the cellular environment, which enables industrial-scale drug discovery using novel screening technologies and structure-based drug design.

The series A financing was led by Third Rock Ventures, with significant support from Samsara BioCapital, BVF Partners, Invus Financial Advisors, Catalio Capital Management, Casdin Capital, and Logos Capital.


Copyright © 2022 scienceboard.net
 

Create an Account

Already have an account? Sign in Here

To access all ScienceBoard content create a free account now:



Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

 
I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.

Email Preferences



Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.